🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07003230
Starting soon Not applicable

Effect of Vegan Diet on Microbiome and Metabolism

NCT07003230 · tracked via the Priya Life Science China tracker
Sponsor
Zhujiang Hospital
Phase
Not applicable
Started
2025-05-30
Last updated
2025-06-04

Condition(s) studied

Vegan Diet

Investigational drug(s) / intervention(s)

vegan and omnivorous diet

vegan and omnivorous diet: Participants underwent a 2-week omnivorous diet intervention, followed by a 2-week vegan diet intervention

Study summary

The goal of this interventional study is to investigate how vegan diet affects health in healthy volunteers, Men and women ages 20 - 30 years old. The main questions it aims to answer are:

Change in Microbial community composition and metabolic alterations Changes in plasma metabolic profile. Researchers will compare changes in microbiota and plasma metabolites profile to see the influence of vegan diet in health. In the dietary trial, participants were first assigned to a 2-week omnivorous diet phase, then switched to a 2-week vegetarian diet phase

Eligibility

Sex
ALL
Min age
20 Years
Max age
30 Years
Healthy volunteers
Accepted
Inclusion Criteria: healthe Participants, ages 20-30 years old Exclusion Criteria: 1. Oral antibiotic use or acute/chronic inflammation within the past 3 months; 2. Hormone intake within the past 3 months; 3. Use of any known interfering medications (e.g., insulin, glibenclamide, indomethacin, phentolamine, furosemide, phenytoin sodium, cortisone, etc.) or probiotics within the past month that may affect glucose or lipid metabolism; 4. Smoking or alcohol consumption; 5. Uncontrolled mental disorders (including a history of psychiatric hospitalization); 6. Currently participating in a weight loss or weight management program; 7. Following a special or medically prescribed diet (e.g., for celiac disease); 8. Comorbid cardiac or renal insufficiency; 9. Chronic constipation; 10. Hypertension; 11. Diabetes mellitus.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Zhujiang hospital Guangzhou Guangdong

More Zhujiang Hospital trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07003230 on ClinicalTrials.gov ↗ ← All trials in China